Manganese
Madness
By David Goodman, PhD
When Jonathon Ericson, environmental health scientist,
began planning a two-day conference on toxic metals, his thoughts turned
to the internal combustion engine. Day One he dedicated to lead of the
tetraethyl variety added to silence engine knock. For fifty years, no-knock
gasoline containing tetraethyl lead has spewed metallic wastes out of
millions of tailpipes, tainting the soil and water—and the lungs and brains
of little children.
For Day Two, Ericson planned to focus on MMT, an antiknock
ingredient containing manganese. He issued invitations to speakers who
could discuss the dangers of manganese to the brains of miners in Europe,
Asia, South America and Australia who, after a few years on the job, run
an increased risk for Parkinson's Disease. The manganese particles they
inhale through the lungs then move to the brain with devastating effects.
Left with invitations for the final two conference speakers,
Ericson turned away from internal combustion engines, tailpipes and toxic
exhausts. Instead, he focussed on the dangers of a consumer product that
has been on the market for about thirty years—the plastic bottle filled
with soybean-based infant formula.
How a bottle of soy formula can be mentioned on the same
program with a smoking exhaust pipe and brain damage in manganese miners
is what kept the UC Irvine conference audience captivated. The soy story
told by speakers Francis Crinella of the UC Irvine faculty and Trinh Tran
from the UC Davis Department of Animal Studies unfolded like a Stephen
King novel, complete with mindless villains, thickening plot and innocent
victims too young to defend themselves.
Ericson's conference took place in September, 2000 at
the University of California at Irvine. His two final speakers, Crinella
and Tran, suggested that infants sucking on nipples of plastic bottles
containing soy-based formula could absorb toxic amounts of manganese into
their rapidly developing brains.
The melodrama—no, the tragedy—of toxic manganese in infant
formula begins in 1980 when the Federal Government's Food and Nutrition
Board established safe and acceptable values for manganese in adults,
toddlers and infants. Permissible levels for the three age ranges were
set at 2.5-3.0 mg/day in adults, 1.0 to 1.5 mg/day in toddlers and 0.5
to 1.0 mg/day in infants. The "safe" level for infants soon translated
into soy formula products purchased by millions of mothers.
Despite government assurances, Phillip Collipp, a pediatric
physician at Nassau County Medical Center in 1983 tested for the manganese
in popular soy brands available locally, including Isomil, ProSoybee and
Nursoy. They contained from 0.2 to 1.0 mg of manganese per quart of infant
formula. Later that year, Bo Lönnerdal and Carl L. Keen, of the Department
of Nutrition of UC Davis, tested baby formula taken from pharmacy shelves
in eight countries. The manganese concentrations they found in soy formulas
were higher, ranging from 0.4 to 2.2 mg; the mean value of 1.2 mg vastly
exceeded the infinitesimal 0.005 mg found in human breast milk.
Nutritional scientists have reported how newborn babies
absorb manganese from breast milk. Tiny amounts suckled daily a dozen
times by the baby supply an adequate quantity of manganese to catalyze
50 biochemical reactions. The newborn's digestive system seems superbly
attuned to absorb the scanty amounts of manganese it needs from its mother's
milk.
However, soy formula, containing up to 200 times the manganese
of breast milk, overloads the little body. The baby's immature liver cannot
handle the load. With each swallow increasing the manganese content in
its digestive track, what does the baby do to dispose of the excess? Bo
Lönnerdal, a researcher from UC Davis, explained that in newborns, ingested
manganese rises to high levels in the blood plasma and red blood cells
and then permeates the liver, kidneys and other soft tissues of the body,
including the brain. Only later, at the time of weaning, can the infant
metabolize such large amounts of manganese.
Francis Crinella calculated that by eight months, an infant
fed soy formula daily absorbs approximately 1.1 mg of manganese above
metabolic need. "A significant amount, about 8 percent, is deposited in
a brain region vulnerable to threat of manganese attack."
Neurology textbooks identify manganese as a neurotoxic
metal. In 1837, an English physician noted that some workers in a manganese
mill appeared lethargic and their faces unexpressive. By the turn of the
century, the disease of "manganism" had been described in medical journals.
The disease struck miners exposed to toxic dust, and appeared to cause
emotional lability, irrationality, hallucinations and impulsivity. Chronic
exposure produced more severe symptoms, including muscular weakness, difficulty
in walking, tremor, immobile facial expression, and speech disturbances—symptoms
reminiscent of Parkinson's Disease. Sufferers of the Parkinson's-like
neurological disease secondary to chronic poisoning accumulate large amounts
of manganese in a circumscribed region of the brain.
The primary site of manganese toxicity regardless of the
route of exposure—by mouth, inhalation or injection by intravenous tube—in
humans, monkeys, rabbits and rats, is a mass of nervous tissue buried
deep within the cerebral hemispheres. This is the basal ganglia, part
of the extrapyramidal system controlling body movement. The neuronal damage
caused by the manganese tends to be more extensive in young, immature
animals than in adults.
Six years ago, tragic incidents in two London hospitals
alerted the medical community to the vulnerability of sick babies to manganese
attack. Suffering liver disease, the babies received nutrient solutions
containing small amounts of manganese through intravenous tube feeding.
Although the manganese concentration was no greater than that in soy formula,
and considered safe by government standards, it caused brain damage after
feeding periods lasting a few months to two years. Of 57 babies receiving
"safe" amounts of manganese, two fell ill with movement disorders and
six suffered damage to their basal ganglia.
John Donaldson, toxicologist and speaker on Day Two at
the UC Irvine conference, described how manganese could cause a biochemical
lesion in the basal ganglia. He reported how manganese overload can step
up the brain's electric charge, increase its virulence tenfold, and attack
vulnerable dopaminergic neurons.
Arvid Carlsson, last year's Nobel Prize winner in medicine,
has shown that damage to these basal ganglia dopamine cells is symptomatic
of Parkinson's Disease. At the conference, Donaldson warned that when
"incredible" amounts of manganese are fed to infant mammals, the metal
is capable of "running amok" in the basal ganglia dopamine nerve cells.
"After chronic early exposure, they can be brain-damaged later in life,"
he said.
When Francis M. Crinella, Clinical Professor of Pediatrics
at the University of California at Irvine, spoke, he described the effects
of manganese overload in adolescents. His research had detected relatively
high levels of manganese in the scalp hair of hyperactive children compared
to matched controls. This replicated earlier studies by UC Irvine psychiatrist
Louis Gottschalk, who detected elevated manganese in scalp hair of youths
detained for felony crimes and incarcerated in four Southern California
prisons. These findings, wholly unexpected, persuaded Crinella to launch
inquiry into the most likely source of manganese in the hair, then to
ask whether this had anything to do with hyperactivity in children, a
syndrome attributed to a disturbance in the basal ganglia. To Crinella,
the low levels of manganese in California soil, air and water meant the
primary intake had to be through diet. Since adolescents are able to metabolize
at least 97 percent of manganese ingested, exposure had to occur earlier
in life, possibly during infancy. This hypothesis was first stated by
Collipp in 1983 who had tested hair samples of babies fed soy-based infant
formula and found them high in manganese. Crinella speculated that soy
infant formula might provide one explanation for the current epidemic
of adolescent violence sweeping the nation.
Crinella contacted his colleague Bo Lönnerdal at UC Davis
to take a further look at the effects of manganese on the brain, particularly
its toxicity to dopamine neurons in the basal ganglia. Lönnerdal and a
graduate student Trinh Tran tested for behavioral and brain disorders
in rat pups. For 18 days, four groups of rat pups suckled on the mother's
breast and received by micropipette an additional dose of manganese salt
dissolved in water. The doses corresponded to the amounts of manganese
found in rat breast milk (0.05 mg) and several brands of soy-based infant
formula (0.25 mg and 0.50 mg) found on pharmacy shelves today. The control
group received just sugar water (0.0 mg). After 18 days of controlled
feeding, the rat pups were returned to their cages and left undisturbed
until 50 days of age. Then through Day 64 they were given behavior tests
for evidence of disability. The animals given high amounts of manganese
did less well on maze and shock avoidance than those given lesser amounts.
The audience now turned their attention to the next paper,
by Francis Crinella, on levels of basal ganglia dopamine. Crinella's data
were clear-cut, unmistakable and replete with implications. Rats given
0. 05 mg of manganese daily for 18 days, the amount comparable to the
manganese in breast milk, did as well as the control group given no manganese.
Rats given supplemental manganese in the dose five times higher, or 0.25
mg, suffered a 48 percent decline in levels of basal ganglia dopamine.
The rats dosed daily with the highest amount, 0.50 mg, had a staggering
63 percent plunge in dopamine.
When asked the meaning of these dramatic findings, Crinella
answered that many labs previously had reported the toxic effects of manganese.
The basal ganglia frequently were the target for neurotoxic effects. Dramatic
declines in dopamine due to manganese overload had been reported before.
He also described the lingering threat of toxic alterations in brain cells
weeks after manganese is discontinued.
The value of Crinella's data and that of Trinh Tran was
that they provided a link between a moderate manganese exposure during
early infancy, dopamine neurotoxicity and the possibility of cognitive
disorders in later life.
"The brain undergoes a tremendous proliferation of neurons,
dendrites and synapses during the first months of life. Some neurons will
be pruned during childhood for maximum information efficiency," said Crinella.
"The brain is especially vulnerable in early life precisely because such
rampant growth is taking place, and at that time intrusions by potentially
toxic substances like manganese perturbing the emerging neural organization
can exert long-term effects. Manganese ingested during a period of rapid
brain growth and deposited in the critical basal ganglia region may affect
behavior during puberty when powerful stresses are unleashed on the dopamine
neurons and altered behavioral patterns appear." According to Crinella,
these altered behavioral patterns during late childhood and early adolescence
may be diagnosed as hyperactivity with attention deficit disorder.
Or perhaps as a "manganese toxicity syndrome." Crinella's
presentation provoked much discussion. Is the manganese ingested in soy
formula at infancy a source for behavioral disorders later on? Bo Lönnerdal
and Carl Keen were impressed by the findings but warned against premature
generalization. Young rats appear more susceptible than human babies to
manganese toxicity. They absorb 80-85 percent of the manganese they ingest,
while the figures for human infants at six months old are closer to 35
percent. It is in providing the worst-case scenario of what can happen
to human infants fed manganese that the rodent research may prove most
instructive.
A dissenting opinion about soy dangers came from John
Lasekan, a pediatric nutritionist at Ross Products Division of Abbott
Laboratories. His published research claims that manganese is a trace
metal absolutely essential for life and that premature and low birth weight
infants may be at risk for developing a deficiency in manganese. He claims
that the soy-based formulas support normal growth and normal plasma biochemistry,
comparable to infants fed human milk during at least two months of life.
Mardi Mountford, spokesman for the International Formula Council adds:
"There are no reports of manganese toxicity in healthy infants fed soy
formula. Parents can be assured that infant soy formulas are safe and
nutritious feeding options for their infants."
Yet some remain unconvinced. "It's overwhelming," says
Everett "Red" Hodges, founder of the Violence Research Foundation, citing
the evidence supporting Crinella's hypothesis that infants ingesting soy-based
infant formula at the levels available in commercial products 15 years
ago might be at risk. "Criminals aged sixteen and seventeen years old
today, some of whom were born to poor mothers in 1983 and 1984, could
have received from the government soy formula with enough manganese to
disrupt growing brains, and this may be why these adolescents have difficulty
restraining aggressive impulses today."
Stanley Van Den Noort, a neurology professor and former
Dean of the UC Irvine College of Medicine, agrees with Hodges and Crinella.
"I think the data presented at the conference are convincing that manganese
is a neurotoxin. Newborn infants exposed to high levels of manganese may
be predisposed to neurological problems. We should exercise strong caution
in the use of soy-based formula around the world."
Whether or not the manganese in soy formula today, with
an average value of 0.16 mg per quart (0.15 mg per liter), poses an acute
danger may be secondary to the issue of why more and more mothers in the
United States imagine they have given birth to a baby soy bean instead
of a human child. "Why else feed so many newborn infants soy ‘milk'?"
asks Naomi Baumslag, Clinical Professor of Pediatrics at Georgetown University
Medical College and President of the Woman's International Public Health
Network. For years Baumslag has waged a campaign against the medical profession's
cavalier attitude towards soy infant formula. "Only 50 percent of newborns
today suckle at the mother's breast, even once. After six months, the
number has fallen to only one mother in five. Often, mothers for the sake
of convenience plunk soy bottles into the infant's mouth. Sales of soy
formula have doubled during the past ten years." Baumslag states, "There
is great deal of scientific evidence that soy formula can be damaging
to newborns, quite aside from the manganese." Soy "milk" can be dangerous
for what it has and does not have. A spoonful of soy formula lacks many
nutritional, immune and developmental factors. The spoonful may be deficient
in linoleic and oleic essential fatty acids, DHA-brain growth factor,
epidermal growth factor, lactoferrin, casomorphin, and immune factors
like IgA, neutrophils, macrophages, T-cells, B-cells and interferon that
mother's milk provides to defend her baby. The spoonful of soy "milk"
unfortunately, does contain phytates, protease factors, soy lectins, enormous
amounts of phytoproteins, and genistein, a moderately potent estrogen-mimic
in humans. She asks, "Why deprive the newborn infants of perfectly good
breast milk—nutritionally superior food in every way for the baby—and
feed them soy beans?"
The powers in government and corporations have not reacted
to these voices raised against the potential dangers of manganese in soy
infant formula. The government can hardly be unaware of the simple logic:
(1) Excess manganese is toxic. (2) Babies absorb excess manganese. (3)
Excess manganese is toxic to babies. Carl L. Keen believes that the original
administrative problem was that the government established teenage requirements
for manganese, then extrapolated backwards to determine a level they believed
to be safe and acceptable for toddlers and newborns. The problem of infant
exposure to excessive manganese identified 15 years ago still persists,
but what can scientists like Drs. Keen and Crinella do about it?
Sitting at his desk in the Social Ecology building, Jonathon
Ericson pondered how he could bring the soy infant formula problem to
the public's attention. Why not, he thought, provide the answer at the
end of the two-day conference? Day One would fill the audience's mind
with indisputable evidence that a lead compound of the tetraethyl variety,
from inception as a gasoline additive in the 1920s until its removal from
fuel in the 1980s, was causing brain damage in children around the world.
Day Two would extend the warning to manganese, both in the antiknock compound
MMT and as a contaminant in baby formula. What he did was invite two government
policy makers, Robert Presley and Phillip Lee, to discuss what society
must do today to resolve the soy formula crisis.
Chairing the panel was Senator Robert Presley, California
State Secretary of the Adult & Juvenile Corrections Agency, responsible
for 170,000 incarcerated felons. Presley thanked Jon Ericson for providing
him with the challenge. His solution was to recommend increased funding
for studies of brain development. When asked why this was important, he
said, "Somewhere in the soy formula story may lie the answer to a lot
of crime." Phillip R. Lee, Former U.S. Undersecretary of Health and Human
Services, now Senior Advisor to the Institute for Health Policies, took
a moment to applaud independent research. Then he offered his advice:
"The MRI scan detected brain damage in the sick babies in London. In the
U.S., we might identify sensitive populations of newborns, then launch
longitudinal studies combining the scans and behavioral testing to find
out what infant feeding has to do with aberrant behaviors occurring during
late childhood years."
Two conclusions emerge from the conference. First, the
need to educate the public about the potential dangers posed by the soy
formula now fed to 750,000 infants per year. Second, to accelerate studies
on the effects of toxic metals on the brain and on human behavior.
How the unfolding melodrama will end, nobody knows. Since
the September, 2000 conference, scientists are stepping up their efforts
to pinpoint the manganese syndrome. They are investigating the effects
on calcium and iron deficiency in pregnant rat dams, known to enhance
uptake of manganese in the infant. Second, they are going to look more
carefully at the effects of manganese excess in infant primates.
Meanwhile, manganese levels in soy formula remain high.
One soy-based product on the shelf today provides up to 0.72 mg manganese
daily. And soy products for infants sold in foreign countries can be even
higher.
In 1983, Phillip Collipp offered the following advice
to the formula industry: "Reduce manganese in infant formula to the levels
found in human milk." So far, the industry has not responded.
David Goodman,
PhD is a neuroscientist and journalist whose popular writings feature
information on healthy brain development and its enemies.

|